Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Pediatrics

178,864 Journal Article Views | Journal Analytics

Nasal and Buccal Treatment of Midazolam in Epileptic Seizures in Pediatrics

Submit a Paper



Publication Date: 24 Jul 2012

Type: Review

Journal: Clinical Medicine Insights: Pediatrics

Citation: Clinical Medicine Insights: Pediatrics 2012:6 51-60

doi: 10.4137/CMPed.S8330

Abstract

Acute seizure and status epilepticus constitute major medical emergencies in children. Four to six percent of children will have at least one seizure in the first 16 years of life. Status epilepticus is a common neurological emergency in childhood and is associated with significant morbidity and mortality. The early application of antiepileptic treatment is very important. Because early treatment prevents the status epilepticus formation and shortens the duration of seizure activity. For this reason administration of anticonvulsant therapy in the prehospital setting is very important. Seizures generally begin outside the hospital, and thus parents and caregivers need simple, safe and effective treatment options to ensure early intervention. The only special preparation used for this purpose is rectal diazepam but has some disadvantages. Midazolam is a safe, short-acting benzodiazepin. It is suitable to use oral, buccal, nasal, im and iv routes. This provides a wide area for clinical applications. Recently there are many clinical studies about the usage of nasal and buccal midazolam for treatment of pediatric epileptic seizures. The nasal and buccal applications in pediatric seizures are very practical and effective. Parents and caregivers can apply easily outside the hospital.


Downloads

PDF  (484.01 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




Our Service Promise

  • Prompt Processing (3 Weeks to Editorial Decision)
  • Fair, Independent Peer Review
  • High Visibility & Extensive Indexing
What Your Colleagues Say About Clinical Medicine Insights: Pediatrics
The publishing experience in Libertas Academica journals is unique. Readers can feel satisfied that publications are peer reviewed. Authors follow simple steps to reach final stage of publication. All readers have access to articles. Journal subscriptions or medical library access is not needed.
Dr Akram Al Hilali (Consultant Hematopathologist, Dubai Health Authority, Dubai)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results